Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trial Watch: Lenalidomide-based immunochemotherapy.
Semeraro M, Vacchelli E, Eggermont A, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Semeraro M, et al. Among authors: galon j. Oncoimmunology. 2013 Nov 1;2(11):e26494. doi: 10.4161/onci.26494. Epub 2013 Oct 21. Oncoimmunology. 2013. PMID: 24482747 Free PMC article. Review.
Trial Watch: Monoclonal antibodies in cancer therapy.
Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: galon j. Oncoimmunology. 2012 Jan 1;1(1):28-37. doi: 10.4161/onci.1.1.17938. Oncoimmunology. 2012. PMID: 22720209 Free PMC article.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Kroemer G. Vacchelli E, et al. Among authors: galon j. Oncoimmunology. 2012 Mar 1;1(2):179-188. doi: 10.4161/onci.1.2.19026. Oncoimmunology. 2012. PMID: 22720239 Free PMC article.
Trial Watch: Adoptive cell transfer immunotherapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: galon j. Oncoimmunology. 2012 May 1;1(3):306-315. doi: 10.4161/onci.19549. Oncoimmunology. 2012. PMID: 22737606 Free PMC article.
Trial Watch: Immunostimulatory cytokines.
Vacchelli E, Galluzzi L, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: galon j. Oncoimmunology. 2012 Jul 1;1(4):493-506. doi: 10.4161/onci.20459. Oncoimmunology. 2012. PMID: 22754768 Free PMC article.
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: galon j. Oncoimmunology. 2012 Aug 1;1(5):699-716. doi: 10.4161/onci.20696. Oncoimmunology. 2012. PMID: 22934262 Free PMC article.
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.
Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: galon j. Oncoimmunology. 2012 Sep 1;1(6):894-907. doi: 10.4161/onci.20931. Oncoimmunology. 2012. PMID: 23162757 Free PMC article.
Trial watch: Dendritic cell-based interventions for cancer therapy.
Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Among authors: galon j. Oncoimmunology. 2012 Oct 1;1(7):1111-1134. doi: 10.4161/onci.21494. Oncoimmunology. 2012. PMID: 23170259 Free PMC article.
236 results